News & Updates
Filter by Specialty:
Hong Kong’s first support programme for younger-onset dementia
Hong Kong’s first younger-onset dementia (YOD) support programme is launched recently to provide free diagnostic, referral and follow-up services to individuals aged 40–65 years with suspected or diagnosed YOD.
Hong Kong’s first support programme for younger-onset dementia
24 Feb 2023
Social support benefits individuals prone to depression under stress
A nurturing social environment turns out to be helpful to individuals who are genetically at greater risk for developing increased depressive symptoms under adverse social conditions, as shown in a study.
Social support benefits individuals prone to depression under stress
20 Feb 2023
Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE
Young patients with newly diagnosed systemic lupus erythematosus (SLE) are vulnerable to psychiatric comorbidity, which tends to increase healthcare utilization, according to a study.
Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE
09 Feb 2023
EULAST: No clear benefits in prescribing long-acting over oral antipsychotics for early-phase schizophrenia
Long-acting injectable antipsychotics (LAIAs) showed no substantial advantage over oral antipsychotics in terms of time to discontinuation in patients with early-phase schizophrenia, the EULAST trial has demonstrated.
EULAST: No clear benefits in prescribing long-acting over oral antipsychotics for early-phase schizophrenia
03 Feb 2023
Antipsychotic prescriptions for dementia soared during COVID-19 pandemic
The overall rate of antipsychotic drug prescriptions to patients with dementia increased markedly during the initial months of the COVID-19 pandemic, and did not return to prepandemic levels when the acute phase was over, a multinational network cohort study has shown.
